Sl0043 40501

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Lupus (SLE)

Closed trials

• Completed

  A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

  NCT04294667· Phase 3· UCB Biopharma SRL· Source